Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: Abbott Laboratories logo is displayed on a screen at the NYSE in New York (Reuters) -Abbott Laboratories will stop ...

The US Food and Drug Administration (FDA) on Wednesday issued a warning letter to Abbott Laboratories for making unapproved claims about its infant probiotic, Similac Probiotic Tri-Blend for infants.

The FDA warned the public Thursday that certain probiotic products given to preterm infants in hospital settings are potentially dangerous. The agency also sent warning letters to Abbott Nutrition and ...

After the FDA told hospitals to not give preterm infants probiotics following one baby’s death, the agency sent warning letters to Abbott Laboratories and Infinant Health. Probiotics are commonly ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Abbott Laboratories has agreed to discontinue sales of its ...

Add Yahoo as a preferred source to see more of our stories on Google. Preterm infants should not be given probiotics, as the products can pose serious risk to babies and have been linked to at least ...

GREEN BAY, Wis. (WBAY) - A popular baby formula company is recalling one of its products, saying your baby could get serious reactions from it. This is a voluntary recall by Abbott Laboratories for ...

Probiotics could have fatal consequences for infants, the Food and Drug Administration (FDA) has warned. The agency issued a warning on Thursday that probiotics — which contain live bacteria and ...

The FDA has issued a general warning and a specific warning letter regarding the use of probiotics in pre-term infants. Some products have been linked with more than two dozen reported “adverse events ...

Adds details on infant death in paragraph 5, background on previous Abbott baby formula issue in last paragraph Oct 26 (Reuters) - Abbott Laboratories ABT.N has agreed to discontinue sales of its ...

(Reuters) -Abbott Laboratories will stop sales of its Similac Probiotic Tri-Blend product used for hospitalized preterm infants after the U.S. Food and Drug Administration issued a warning letter, the ...